EMBO at Basel Life

A new conference on current and emerging life science research

14-Sep-2017 - EMBO and Basel Life hosted EMBO at Basel Life conference. A committee of leading scientists had organized this international and broad-scope scientific conference on current and emerging life science research to be held as part of Basel Life. “Established and young researchers will present and ...

A patent-free playground

Researchers and industrial companies collaborate to create a new Open Science platform

01-Aug-2017 - Along with a number of leading Danish industrial companies, Aarhus University has opted out of the patent rat race in a new collaboration on industrially relevant basic research. Researchers and companies from all over Denmark publish all their results and data on the innovative Open Science ...

Molecular simulations confirm role of functional rotation in multidrug resistance

22-Nov-2010 - A new molecular simulation technique developed by researchers at RIKEN and Kyoto University has confirmed for the first time the function of the transporter protein AcrB in E. coli multidrug resistance. The result marks a key step in efforts to combat antibiotic resistance, demonstrating the ...

caprotec bioanalytics appoints Prof. Dr. Metternich as Managing Director, Chief Business Officer and Chief Operating Officer

06-Oct-2010 - caprotec bioanalytics GmbH announced the appointment of Prof. Dr. Rainer Metternich as Managing Director, Chief Business Officer and Chief Operating Officer of the company. Prior to joining caprotec, Prof. Metternich held senior leadership positions at Merck & Co., Schering AG and ...

Specialist Business Unit of the University of Nottingham Spins-Out to Form New R&D Oncology Company

13-Sep-2010 - Preclinical Oncology Services Limited (PRECOS), a pre-clinical research and development service with a specific focus on oncology, announced its official launch following its spin-out from the University of Nottingham. The newly formed company combines the innovation of one of the university with ...

Generex Oncology Names Dr. Craig Eagle to its Scientific Advisory Board to Assist with its Proprietary Cancer Vaccines Program

09-Aug-2010 - Generex Biotechnology Corporation announced that it has named Craig Eagle, M.D. to its scientific advisory board. Dr. Eagle brings a wealth of oncology experience to help the Company’s wholly-owned subsidiary, Antigen Express, Inc., dba “Generex Oncology”, further its synthetic cancer and ...

Capital for fluorescent mini-antibodies

19-Jul-2010 - High-Tech Gründerfonds and Bayern Kapital are investing about EUR 400k in Chromotek GmbH. The investment is intended to fund research and development work aimed at ensuring successful market entry for chromobody technology in the field of living cell analysis. Chromotek GmbH, an enterprise spun ...

Technique enables precise control of protein activity in living cells

28-Jun-2010 - Cancer occurs when human cells move and multiply inappropriately. Within cells, a process called phosphorylation serves as an on/off switch for a number of cellular processes that can be involved in cancer, including metabolism, transcription, configuration, movement, cell death and ...

Lowering pH regulates spider’s silk production

17-May-2010 - How can a tiny spider body contain material for several decimeters of gossamer silk, and what governs the conversion to thread? Researchers at the Swedish University of Agricultural Sciences (SLU) can now explain this. The new research findings are presented in Nature. “We have seen how the ...

Researchers discover metabolic vulnerability in TB and potential drug target

14-May-2010 - Tuberculosis (TB) has been present in humans since ancient times. The origins of the disease date back to the first domestication of cattle, and skeletal remains show prehistoric humans (4,000 B.C.) had TB. The cause of tuberculosis is Mycobacterium tuberculosis (Mtb), a slow-growing aerobic ...